Teva Women's Hurricane XLT3 Closed-Toe Sandal

Teva Women's Hurricane XLT3 Closed-Toe Sandal

Marsoni

M251S

$130.00

Get it in 3 business days with 1 day shipping. Friday, May 29

Teva Women's Hurricane XLT3 Closed-Toe SandalYour all day, take on anything adventure companion, the next generation Hurricane XLT3 CT is the epitome of rugged. A closed toe sport sandal that delivers durable, trail ready traction, weve enlisted a quick dry mesh upper, bungee lace, and toothy lug pattern for expert traction. Closed Toe Confidence The closed toe design delivers protective coverage with the breathability of a sandal. More Foam Means More Comfort Added underfoot foam and a

Easy Shipping

Quick Dispatch:

Your Teva Women's Hurricane XLT3 Closed-Toe Sandal orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your Teva Women's Hurricane XLT3 Closed-Toe Sandal ships.

Need Help?
Questions about Teva Women's Hurricane XLT3 Closed-Toe Sandal, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for Teva Women's Hurricane XLT3 Closed-Toe Sandal in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

As described, a tad overpriced, length is good, the end crimps very easily so it doesn't last long, does get warm when you touch it after a long time plugged in, it's functional, we bought several of the same in the past they've all had the same story functional get a little warm the middle part on hooks easily, which does make it hard when you're trying to charge something

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on May 18, 2026